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BIRTH WEIGHT AS A RISK FACTOR FOR AUTISM SPECTRUM DISORDERS: A 
PILOT STUDY AND CASE-CONTROL STUDY. 
Virginia Grace Cohen; Myriam Peralta-Carcelen and Crayton Fargason (Department of 
Pediatrics, University of Alabama School of Medicine); Fred Volkmar (Child Study 
Center, Yale University School of Medicine) 
The role of birth weight and perinatal adversity in the development of autism 
spectrum disorders (ASDs) remains controversial. Our objective was to clarify the 
relationship between ASDs and low birth weight, with particular focus on the effects of 
extremely low birth weight (ELBW). In part one of this study, we tested a cohort of 
ELBW children ages 3-7 for ASDs using the Autism Diagnostic Observation Schedule 
(ADOS) as our primary assessment tool, and the Autism Behavior Checklist, Autism 
Screening Questionnaire, and the Vineland Adaptive Behavior Scales as secondary tests. 
Of 19 ELBW participants, 3 had ADOS total scores in the ASD or autism range; one of 
the three scored in the ASD range on all tests administered. In addition, 7 had abnormal 
scores on the ADOS communication domain, and 4 on the social interaction domain. In 
part two, we conducted a case-control study to look at birth weight and perinatal 
adversity in children with autism or pervasive developmental disorder vs. controls. In 
this portion of the study (n=296), mean birth weight was not significantly different 
among the autism, PDD, and control groups (p=0.523). In those with IQ<70, there was a 
noticeable but nonsignificant trend toward higher birth weight in the autism group 
(p=0.132). There were no differences in specific adverse perinatal factors among groups. 
While our data suggest that low birth weight and perinatal adversity are not major risk 
factors for ASDs, more research is necessary to determine whether the small subgroup of 
ELBW children may have a tendency to develop autism-like behavioral derangements. 
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1 
Introduction 
Since autism was first described by Leo Kanner in 1943, the etiology of this 
mysterious disorder has fascinated both the medical community and the general public. 
Interest has been sparked in recent years by what appears to be a significant increase in 
the prevalence of autism spectrum disorders, a puzzling phenomenon that has not yet 
been fully explained. As the number of American children with autism and related 
conditions has grown, so has recognition of the critical importance of research into this 
field; in the fall of 2003, the federal government launched a long-term initiative aimed at 
promoting biomedical research, establishing better screening and diagnostic tools, and 
formulating more effective therapies for autistic disorders (1). In this climate, defining 
and understanding the risk factors for autism is a necessary step in early diagnosis and, 
ultimately, prevention of the disorder. 
Autism is characterized by qualitative deficits in communication and reciprocal 
social interaction, and by repetitive or stereotyped behaviors and interests (see Appendix 
A for full diagnostic criteria [2]). Onset occurs in early childhood, usually before age 
three. Autism is frequently marked by language delay and impoverished imagination, 
and is more likely to affect boys than girls (3). Intellectual function is impaired in 
approximately 75% of children with autism; one recent meta-analysis (4) demonstrated 
that 23.5% of autistic subjects were without intellectual impairment, 22.3% had mild to 
moderate impairment (IQ 35-70), and 54.9% had a severe to profound level of mental 
retardation (IQ <35). Autism spectrum disorder (ASD), synonymous with pervasive 
developmental disorder (PDD), is an umbrella term that encompasses a variety of related 
disorders — such as Asperger syndrome, PDD not otherwise specified (PDD-NOS)), 
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atypical autism, and autism itself — that span a continuum of social and communication 
deficits. 
The incidence and prevalence of ASDs are somewhat controversial, with 
prevalence estimates increasing dramatically over the last decade. Recent meta-analyses 
(5,6) of epidemiological studies conservatively estimate the prevalence of autism to be 
about 10 per 10,000 (up from estimates of 2-5 per 10,000 in the 1970s) and the 
prevalence of ASDs to fall between 20 and 50 per 10,000. One of the more recent 
prevalence studies (7), published in June of 2001, found a rate of 16.8 per 10,000 for 
autistic disorder and 62.6 per 10,000 for ASDs, inclusive of autism. Other research (8- 
10) has yielded even higher numbers: 21-40 per 10,000 for autism and 58-67 per 10,000 
for all ASDs combined. At present, it is not known whether these growing numbers 
reflect changing diagnostic definitions of autism and ASDs, heightened awareness among 
healthcare professionals and the public, a true rise in incidence, or some combination of 
these factors. Data from the Minnesota public school system (11) suggests that while 
autism rates have been rising, there have been no decreases in other categories of 
educational disability to suggest diagnostic substitution as the sole explanation for the 
increasing ASD rates. Regardless of the reason for the rise, however, disorders of this 
type have become a significant and fairly common pediatric concern. 
Autism spectrum disorders are generally thought to result from a complex 
interplay between genetics and neurobiological factors, likely occurring when 
environmental influences act on a genetically susceptible individual (12,13). The precise 
etiology is unknown in most cases, but an underlying disorder or aberration can be 
pinpointed in a minority of individuals with an ASD (14). Twin and family studies, as 
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well as molecular and cytogenetic research, have established a strong genetic component 
to autism (15-17). Concordance rates are much higher for monozygotic twins (80-90%) 
then for dizygotic (9-30% [18-20]). The reported rate of autism among siblings ranges 
from 2-7%, with siblings of autistic patients 50-200 times more likely to have autism than 
members of the general population (21-22, 13). The genetics of autism are certainly 
complex, likely involving multiple genes that have yet to be identified. 
Associations have been demonstrated between autism and tuberous sclerosis, 
neurofibromatosis, fragile X syndrome, and seizure disorders (23-26). Congenital 
infections, lead poisoning, metabolic diseases, brain lesions, and neurochemical 
abnormalities may also be associated with autism, although the evidence for these is 
relatively weak (27). (Of note, several recent studies [28,29] have failed to find any 
association between the measles, mumps, and rubella [MMR] vaccine and the 
development of autism.) Overall, the rate of concurrence between autism and known 
medical conditions is estimated to be about 10-25% (30,31). 
Courchesne and colleagues (32) have recently demonstrated that reduced head 
size at birth, followed at 6-14 months of age by an abnormally accelerated pattern of 
brain and head growth, is associated with autism spectrum disorders. The authors of this 
paper, who noted the unusual growth trajectory in 59% of children with an ASD 
compared to 6% of normal children, have speculated that abnormal brain expansion 
creates “noise” that may limit a child’s ability to learn about and interact with the outside 
world, and a critical window of time in development may be irretrievably lost. Other 
neurologic studies (33,34) have revealed patterns of limbic and cerebellar abnormalities 
in the brains of some autistic patients. 

4 
Because most cases of autism are idiopathic, further investigation into the causes 
and risk factors of the disorder is essential. Some researchers, mindful of the link 
between neurologic insults and autism, have hypothesized that obstetrical complications 
may be a risk factor for the disorder. In 1980, Deykin and MacMahon (35) found that 
autistic children were more likely than their nonautistic siblings to have experienced at 
least one adverse event in the pre-, peri-, or neonatal phase. The authors concluded that 
general physical damage resulting from unfavorable events might lead to the 
development of autism, but that no single complication could be named responsible. 
Several later studies (36-38) have provided further support for the notion that nonspecific 
pre-, peri-, or neonatal factors may contribute to autism, although a consistent pattern of 
risk factors has not been demonstrated. A wide variety of conditions and complications 
including maternal medication use, maternal smoking, increased paternal age, intrauterine 
stress, abnormal presentation at delivery, decreased birth weight, and hyperbilirubinemia 
have been implicated in the last few years with the later development of an ASD (39-42). 
Other studies, however, have called these findings into question. Piven, et al. (43) 
found that adjusting for birth order eliminated apparent differences in obstetrical 
optimality between autistic children and their siblings. Another study of 49 autistic 
children (44) found no difference in maternal age, maternal parity, birth order, or low 
birth weight between the autistic children and controls. Two additional groups have failed 
to find a relationship either between specific pathologic factors or groups of factors and 
autism (45) or between general suboptimality and autism (46). 
Taken as a whole, research into the relationship between autism and obstetric or 
perinatal adversity is inconclusive and merits further study. Even those studies that have 
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found a link between adverse conditions and autism disagree as to precisely which 
conditions are to blame, and it is difficult to find among the potential risk factors any 
unifying features that would suggest pathogenesis. Most existing studies document the 
risk of developing autism, but do not address disorders within the broader autism 
spectrum such as PDD-NOS. Furthermore, no one has yet considered the effects of 
extremely low birth weight, as opposed to low birth weight in general, on the 
development of autistic behaviors. 
As medical advances such as surfactant and maternal steroid use have improved 
survival for infants of low birth weight and gestational age, a new cohort of extremely 
low birth weight (ELBW) children has arisen. Traditionally, low birth weight children 
have been stratified into three categories: low birth weight (<2500g), very low birth 
weight (<1500g), and extremely low birth weight (<1000g). In 2000, according to a 
report by the Center for Disease Control and Prevention, 7.6% of infants bom were low 
birth weight (LBW), and 1.5% were very low birth weight (VLBW). A much smaller 
proportion were ELBW (0.7% according to 1997 data [47]). Survival correlates with 
birth weight and gestational age, ranging from 11.6% for birth weights <500g to 83.9% 
for birth weights of 750-1000g to 98.4% for birth weights of 1500-2500g (48). 
ELBW children, who are typically bom at or before 27 weeks’ gestational age, 
are at greater risk than their higher birth weight counterparts for the various 
complications of premature birth, including chronic lung disease, severe brain injury, 
necrotizing enterocolitis, nosocomial infections, and retinopathy of prematurity (ROP). 
Rates of severe disability, such as mental retardation, cerebral palsy, blindness, and/or 
deafness, are also high in this population (49). (Notably, although the mortality rate for 
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ELBW infants has declined, the proportion of those with severe sequelae has not). 
Overall, about 20% of ELBW are significantly disabled (50); this proportion rises to 50% 
among infants bom between 500-750g (51). 
As they age, ELBW children attain lower growth measurements than their peers 
(52) and are more likely to develop deficits in executive function (affecting planning, 
sequencing, and inhibition) and limitations in cognition, sensation, mobility, and self-care 
(53-55). They experience significantly more neurologic problems than controls, as well 
as reduced visual-motor function, visual-perceptual abilities, and attention span (56). 
Extremely low birth weight has been linked to impaired cognitive and motor 
development in preschool-age children (57) and the need for special education services in 
school-age children (50). Furthermore, school-age ELBW children as a group score 
significantly lower than controls on IQ tests, school achievement tests, and motor 
performance (58). These difficulties follow surviving ELBW children into adolescence, 
where they continue to have a higher prevalence of visual problems, seizures, 
developmental delay, learning disabilities, hyperactivity, and use of community resources 
than controls, although some catch-up growth and improvement in health does tend to 
occur (59). 
Interestingly, although no one has directly investigated the link between ELBW 
and autism, a strong association has been found between autism and blindness due to 
retinopathy of prematurity (ROP), a disease for which risk increases as birth weight 
decreases. In this study (60), undertaken by a group in Sweden, 15 of 27 children in the 
ROP group (with gestational ages between 25-30 weeks) had autistic disorder, and an 
additional 4 had autistic-like conditions. The authors speculated that both blindness from 
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ROP and autism were mediated by brain damage in these children. Only 2 of 14 controls 
(children with congenital blindness secondary to hereditary retinal disease) were found to 
be autistic. 
Although no cure for autism exists, outcome can be markedly improved by early 
diagnosis and intervention (61-63). Current intervention strategies recommended by the 
American Academy of Child and Adolescent Psychiatry and the American Academy of 
Pediatrics include behavior management, structured play therapy, early developmental 
education or school-based special education, and speech, occupational, and physical 
therapy (64, 65). The National Research Council issued a detailed report in 2001 (66) 
with an analysis of available interventions and recommendations for schools, parents, and 
the community on educating children with autism. Pharmacologic treatment is also 
available both for autism-related behaviors and for concurrent psychiatric conditions (67- 
71). In recent years, encouraged by the development of better treatment options and 
diagnostic instruments and by growing concerns over the prevalence of autism, health 
professionals have placed increasing emphasis on the importance of early screening and 
diagnosis of autism and ASDs (72-73, 64). 
In this context, it is vitally important that potential risk factors for autism be 
defined and investigated. In part one of this study, a sample population of ELBW infants 
was tested for autistic behaviors using three instruments, the Autism Diagnostic 
Observation Schedule (ADOS [74]), Autism Behavior Checklist (ABC [75]), and Autism 
Screening Questionnaire (ASQ [76]). Results of the ADOS, an assessment designed to 
differentiate among autism proper, ASDs, and nonspectrum diagnoses based on the 
number and severity of observed behaviors, were used as the primary outcome measure. 
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In addition, the Vineland Adaptive Behavior Scales (77) were administered to assess 
level of development in communication, socialization, and daily living skills. 
Given that extreme prematurity is known to put children at risk for a host of 
developmental and behavioral sequelae, and that the incidence of ELBW survivors and 
prevalence of ASDs have both risen within a similar time frame, we hypothesized that 
this group of children was more likely than the average population to display autism- 
related social and communication deficits and behavioral abnormalities. The primary 
goal of this pilot study was to determine if a more extensive investigation into the link 
between extreme prematurity and autistic behavior is warranted. Because early diagnosis 
and treatment are very important in determining future outcome, this study was designed 
to help clarify whether ELB W is a risk factor for ASDs and whether routine screening for 
autism is called for in this population of children. 
The second part of this study approached the question of low birth weight as a 
risk factor for ASDs from a retrospective angle. A case-control study was performed 
using the medical records of children seen in a Developmental Disabilities Clinic. This 
study compared the birth weights of children with autism or PDD to those of controls 
with mental retardation (MR) or developmental disabilities outside the autism spectrum. 
Using results gathered in part one of the study, it was hypothesized that children with 
autism or PDD would, on average, have lower birth weights than non-autistic controls 
and would also be more likely to fall into LBW, VLBW, or ELBW categories. 
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Statement of Purpose 
Our primary objective in both parts of this study was to determine whether low birth 
weight in general, and extremely low birth weight in particular, is linked to the 
development of autism and pervasive developmental disorders later in childhood. Our 
secondary objective was to investigate the role of adverse perinatal factors in the etiology 
of autism spectrum disorders. 
In the first part of the study, we hypothesized that a cohort of children bom at ELB W 
(<1,000 grams) would demonstrate a higher prevalence of autistic behaviors and autism¬ 
like social and communication deficits than the average population. 
In the second part of the study, we hypothesized that children with autism or PDD would 
have lower mean birth weights than non-autistic controls, and would be more likely to 
fall into low birth weight, very low birth weight, or extremely low birth weight 
categories. 
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Methods 
I. ELBW and Development of Autistic Behaviors 
Study Population 
In part one of this study, we conducted a pilot study with a cohort of ELBW 
children to determine whether a link between ELBW and the development of autistic 
behaviors later in childhood might exist. Study participants were drawn from patients of 
the Newborn Follow-Up (NBFU) Clinic at The Children’s Hospital of Alabama. 
Children between the ages of 3 and 7, with birth weight less than 1,000 grams, were 
eligible for the study. Only patients who lived within one hour of the clinic were 
recruited, and children with significant neurologic impairments such as blindness, 
profound deafness, and cerebral palsy were excluded due to the difficulty of performing 
the ADOS reliably. Parents of children who met the criteria for the study were contacted 
by phone (in the majority of cases) or at clinic visits. Given constraints of time and 
resources, the decision was made not to include a control group in order to maximize the 
number of ELBW subjects that could be tested, and to reduce investigator bias by having 
a selection of videotaped ADOS sessions reviewed by a secondary scorer, unaware of the 
context of the study. 
Study Design 
Approval was obtained from the Institutional Review Board at the University of 
Alabama at Birmingham and from the Human Investigations Committee (HIC) at the 
Yale University School of Medicine. Informed parental consent was obtained at the 
beginning of each testing session. Three validated assessment tools, the Autism 
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Diagnostic Observation Schedule, Vineland Adaptive Behavior Scales, and Autism 
Behavior Checklist, in addition to the experimental Autism Screening Questionnaire, 
were used to evaluate each child’s development, behavior, communicative abilities, and 
social skills (see Appendix B for a brief overview of these assessments). Scores on the 
Vineland, ABC, and ASQ were derived from parental responses, and ADOS scores were 
obtained from observation of the child’s behavior during a set of language-appropriate 
semi-structured activities. The ADOS module to be used was based on the child’s verbal 
level as reported by the parent; module 1 was used for children without spontaneous 
phrase speech, module 2 for those with flexible phrase speech but not fluency, and 
module 3 for those with verbal fluency (at the level of a typical 4-year-old child). ADOS 
sessions were videotaped with parental permission, and were scored by the test 
administrator.1 As mentioned above, a small sample of these videotaped sessions was 
scored independently by an ADOS-certified secondary scorer. 
Demographic information, pregnancy and birth history, medical history, and 
family history were obtained from the parent, as well as a list of medications taken by the 
child. Discharge summaries and psychological tests from the subject’s chart were 
reviewed to provide additional information about neonatal history and to obtain scores for 
previously administered IQ tests. 
Following the study, a report of the outcomes of the four assessments was 
generated for each child, and distributed to parents and the NBFU clinic. Follow-up 
treatment and repeated assessments through the NBFU and Sparks clinics were provided 
for children with unusual or worrisome test results. 
1 The ADOS administrator, the writer of this paper, underwent a one-week ADOS training session and 
established reliability with an ADOS-certified colleague prior to administering the test for research 
purposes. 
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Outcomes 
The results of the ADOS tests were used as the primary outcome measure, with 
results of the Vineland, ABC, and ASQ contributing to the overall analysis. ADOS 
results were compared to published data on the prevalence of autism spectrum disorders 
in the general population; Vineland results were compared to established norms. Within 
the ELBW group, performance on these tests was analyzed with reference to individual 
birth weight and gestational age to determine if correlations existed between these factors 
and the demonstration of autistic behaviors. Because of concerns that low IQ might 
contribute to false positive results on the ADOS, we controlled for IQ (as measured by 
the Bayley Scales of Infant Development, corrected for gestational age, and the 
Differential Ability Scales [DAS]) in these correlations. A variety of participant 
charactenstics and perinatal factors (e.g., mental retardation, seizure disorder, retinopathy 
of prematurity, intraventricular hemorrhage, bronchopulmonary dysplasia) were also 
reviewed with reference to performance on the ADOS. 
Statistical Analysis 
Given the nature of the study, and the relatively small number of children eligible 
for recruitment, we designed the protocol to include as many ELBW children as possible 
during the active phase of the trial. In addition to recording the absolute number of 
“positive” scores on the ADOS and its subsections, we estimated prevalence within a 
95% confidence interval. Within the ELBW group, the Kendall rank correlation 
coefficient was used to analyze correlations between continuous variables such as birth 
weight and test scores, with a partial correlation coefficient used to control for the effects 
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of IQ. Among the ADOS classification groups (autism range, ASD range, and normal 
range), the Fisher exact probability test was used to compare categorical variables and the 
Kruskall-Wallis test was used to compare birth weights. A conventional 2-sided p value 
of less than 0.05 was retained throughout. 
Role of Student 
The medical student and writer of this thesis, under the supervision of Dr. Myriam 
Peralta and Dr. Crayton Fargason (Department of Pediatrics, University of Alabama at 
Birmingham) and Dr. Fred Volkmar (Child Study Center, Yale University School of 
Medicine), helped to design the study and obtain Institutional Review Board approval. 
The student and an assistant recruited all ELBW clinic patients for the study. The student 
was trained in ADOS administration and administered and scored all ADOS tests, which 
were videotaped for secondary review by Kirsten Bailey, a psychology fellow at the 
University of Alabama at Birmingham. The student also obtained all demographic 
information from the parents and patient charts and administered all ABC and ASQ 
parent questionnaires. Approximately 2/3 of the Vineland tests were conducted by the 
student, with the remaining 1/3 conducted by another person involved with the study. In 
addition, under the direction of the advisors named above, the student performed the 
statistical analysis for both portions of this study. 
II. Retrospective Analysis of Birth Weight in Autism and ASDs 
Study Participants 
In the second part of the study, cases and controls were drawn from patients seen 
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in the Developmental Disabilities Clinic of the Child Study Center at Yale University 
School of Medicine. All patients seen in the clinic for whom data on birth weight and IQ 
were available were included in the study. 
Study Design 
After Yale HIC approval was obtained, a review of medical records of children 
with and without autism spectrum disorders was performed. The purpose of this case- 
control study was to compare birth weights of children with autism and other ASDs to 
those of non-autistic controls. Participants were divided into cases, which were then split 
into two groups according to a diagnosis of autism or PDD, and controls. Autism or PDD 
had been diagnosed by experts at the Developmental Disabilities Clinic.2 Control 
subjects had been diagnosed with a variety of non-autistic disorders including attention 
deficit disorder, bipolar disorder, blindness, cerebral palsy, conduct disorder, depression, 
language disorder, learning disability, nonverbal learning disability, reactive attachment 
disorder, social anxiety disorder, schizophrenia, Tourette’s syndrome, or simple mental 
retardation. Due to diagnostic criteria that overlap with disorders within the autism 
spectrum, patients with Childhood Disintegrative Disorder or Multiplex Developmental 
Disorder were excluded to avoid confounding the data. 
2 
Interrater reliability of clinical diagnosis of autism and PDD based on DSM-IV criteria has been shown to 
be excellent among experienced clinicians. In particular, the group of practitioners at the Yale Child Study 
Center, who diagnosed the children in this study, participated in and published results from the DSM-IV 
autism field trial. See Klin A, Lang J, Cicchetti DV, Volkmar FR. 2000. Brief report: interrater reliability 
of clinical diagnosis and DSM-IV criteria for autistic disorder: results of the DSM-IV autism field trial. J 
Aut Dev Disord. 30(2):163-7. 
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Outcomes 
The primary outcome measures were birth weight and gestational age. For 
further analysis, cases and controls were divided according to presence or absence of 
mental retardation, defined as full-scale intelligence quotient (FSIQ) < 70 on the 
Kaufman Assessment Battery for Children (KABC), Leiter International Performance 
Scale, Wechsler Intelligence Scale for Children (WISC), or Wechsler Adult Intelligence 
Scale (WAIS). Secondary outcomes included a variety of factors contributing to 
perinatal adversity, as reported by the child’s parent. These factors include general 
concern about the baby’s condition, excessive maternal bleeding, meconium staining, 
maternal fever and/or infection, forceps use, nuchal cord, placental abnormalities, 
jaundice, use of incubator, feeding difficulties, or oxygen supplementation. 
Statistical Analysis 
The number of subjects in each group needed to demonstrate a statistically 
significant difference among the groups was calculated beforehand, considering both 
alpha and beta error. Using available birth statistics, we assumed a standard deviation in 
birth weight of 500g. We predicted that 63 subjects per group would be needed to detect 
a difference of 250g with a two-sided a value of 0.05. Continuous variables were 
compared using one-way analysis of variance; the chi-square test was used for categorical 
variables. Statistical significance was determined by two-sided p value of .05. 
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Role of Student 
In this portion of the study, the medical student obtained, organized, and analyzed 
data from an existing database of patients seen in the Developmental Disabilities Clinic, 
under the direction of Dr. Fred Volkmar. 
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Results 
I. Autism/ELBW trial 
Of the 268 ELBW children who met criteria for the study, 27 were excluded for 
cerebral palsy, 2 for blindness, and 3 for both cerebral palsy and blindness, leaving 236 
eligible subjects. None of these children had hearing loss severe enough to merit 
exclusion. Of the 236 eligible subjects, 122 were contacted, 42 were enrolled in the 
study, 8 refused, and 72 did not return messages regarding the study. 114 children could 
not be contacted due to wrong numbers or no answer. Reasons given for refusal included 
distance from clinic (1), serious illness (1), time constraints (2), and lack of interest (4). 
Of the 42 subjects initially enrolled in the study, 19 completed all tests required for the 
study and were included in the analysis. (Figure 1) 
Figure 1. ELBW Recruitment Analysis 
268 area ELBW 
children ages 3-7 
32 excluded for CP 236 eligible 
and/or blindness children 
114 not reached* 122 contacted 
80 refused or did 
not respond 
42 enrolled 
19 participated in 
all tests 
ELBW, extremely low birth weight; CP, cerebral palsy 
* due to unavailability of current contact information or failure to answer telephone 
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The baseline characteristics of the 19 children included in the analysis are detailed 
in Table A. Many of the study participants, who were bom at weights ranging from 520 
to 1000 grams, had been affected by various sequelae of prematurity, including 
retinopathy of prematurity (ROP), intraventricular hemorrhage (IVH), bronchopulmonary 
dysplasia (BPD), and cognitive deficits. Using IQ <70 on most recent test (Bayley 
corrected mental age or DAS general conceptual ability) as the criterion for mental 
retardation, four participants were determined to have MR. 
■ ; ’ .V - 
Table A. ELBW Study Participant Characteristics 
' 
N 19 
Mean age 5.33 years (SD 0.95, range 3.25-6.7) 
Mean birth weight 853.47 grams (SD 142.38, range 520-1000) 
Mean gestational age 26.74 weeks (SD 1.88, range 23-30) 
Sex 9 female (47.4%) 
... ’ 
■ 10 male (52.6%) 
Race 9 white (47.4%) 
10 black (52.6%) 
ROP 9 (47.4%) 
Stage 1 5 (26.3%) 
Stage 2 3(15.8%) 
Stage 3 1(5.3%) 
. 
•• • •; ■ 
IVH 6(31.6%) 
Grade 1 3 (15.8%) 
Grade 2 2 (10.5%) 
Grade 3 1 (5.3%) 
BPD 4(21.1%) 
IQ < 70* 4(21.1%) 
ROP, retinopathy of prematurity; IVH, intraventricular hemorrhage; BPD, bronchopulmonary 
dysplasia 
* using latest result on Bayley Scales of Infant Development, corrected for gestational age, or the 
Differential Ability Scales 
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Out of 19 participants, 2 (10.5%) had an ADOS total score in ASD range and 1 
other (5.3%) had a score in the autism range. Several children scored abnormally on one 
or more of the ADOS subsets. For ADOS communication scores, 3 (15.8%) fell in ASD 
range and 4 (21.1%) in autism range; for social scores, 2 (10.5%) fell in ASD range and 2 
(10.5%) in autism range. (Figure 2) 
Figure 2. ADOS Scores of ELBW Participants (n-19) 
 . : 
Classification of ADOS scores 
Normal 
Normal 
r.y 
Autism 
range 
ASD Autism ASD 
range range range Autism 
_'_;__ 
Communication Score Social Score 
ADOS category 
Total Score 
ADOS, Autism Diagnostic Observation Schedule; ELBW, extremely low birth weight; ASD, autism 
spectrum disorder 
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Overall, 3 out of the 19 study participants, or 15.8% (standard error 16.4%; 95% 
confidence interval, -0.6-32.2%), had ADOS total scores in the ASD (2) or autism (1) 
range. All three were males between the ages of four and six at the time of testing; two 
were white and one was black. Only one study participant scored within the ASD range 
on both the ADOS and the parental questionnaires, the ASQ and ABC. No other 
participants scored abnormally on the questionnaires. Test results for children with 
abnormal ADOS scores are summarized in Table B. 
, 
it 
Table B. Test Results for Chi ildren with Abnormal ADOS S< 
; * t 
;ores 
; 
ADOS ADOS ADOS total ABC ASQ 
social comm. 
1 + 
2 + ++ + ++ + 
3 + 
4 ++ 
5 + 
6 + 
7 ++ 
8 ++ + 'ViCi' v - ' ; ’'-r 
9 ++ ++ ++ 
ADOS, Autism Diagnostic Observation Schedule; ABC, Autism Behavior Checklist; ASQ, Autism 
Screening Questionnaire 
Participants with abnormal total ADOS scores (suggestive of autism or ASD) are highlighted. 
+ within testing range for an ASD 
++ within testing range for autism 
ADOS sessions for 6 of the 19 participants, including 2 of the 3 with abnormal 
total scores, were reviewed on videotape and rescored by an independent ADOS-certified 
scorer, blinded to the initial results. The two children with abnormal initial scores were 
again found to be within the autism or ASD range by this secondary reviewer. The 

remaining four subjects were assigned secondary scores that were the same or slightly 
higher than their initial ADOS scores. 
Mean Vineland standard scores for ELBW children were more than one standard 
deviation below the national norm in all categories (Table C), although within the ELBW 
group there were no significant correlations between birth weight and standard or 
composite scores (x =0.054, p=0.752 communication domain; x =0.251, p=0.140 
socialization domain; x =0.222, p= 0.193 composite score). Domain scores were 
uniformly low; mean socialization and communication scores were not significantly 
different from daily living skills or from composite score (p = 0.363). The participant 
with ASD-level scores on the ADOS, ABC, and ASQ had a relatively low socialization 
raw score of 60 compared to scores of 74 in the communication and 88 in the daily living 
skills domains. The other two participants with abnormal ADOS total scores did not 
have socialization scores that were appreciably lower than those in the other domains 
(their scores for the socialization, communication, and daily living skills domains were, 
respectively, 70, 80, 67 and 57, 54, 32). 
Compared to National Norms 
_ 
Table C, 
■; ■ 
ELBW 
Communication 83.42(13.125) 
. 
Daily Living Skills 
Social 
Composite_ 
82.84(13.129) 
84.68 (14.708) 
77.37 (13.238) 
NORM 
100(15.00) 
100(15.00) 
100 (15.00) 
100(15.00) 
ELBW, extremely low birth weight. 
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Because the scoring system and diagnostic cut-offs vary among the three ADOS 
modules used in this study, we used the module with the most data points (module 3, 
n=14) to assess correlation between ADOS scores and other factors; correlations not 
including the ADOS used data from all participants (n=19). Within the ELBW group, 
birth weight did not correlate significantly with scores on ADOS communication domain 
(x =0.061, p=0.775), social (x =0.366, p=0.082) domain, or total (x =0.297, p=0.15). 
There was no difference in birth weight among the three categorical ADOS 
classifications (normal, ASD-range, or autism-range total score; p=0.32). 
Likewise, there was no correlation found between birth weight and total scores on 
the ABC (x = 0.047, p=0.779) or ASQ (x =0.248, p=0.156). However, gestational age 
was found to correlate positively with ADOS social (x =0.650, p=0.004) and total scores 
(x =0.525, p=0.019); that is, later gestational age was related to more abnormal scores. 
IQ was controlled for in the analysis of ADOS, ABC, and ASQ scores. 
Scores on the Bayley Scales of Infant Development, corrected for gestational age, 
correlated positively with ADOS social scores (x =0.468, p=0.037), although no 
association was seen between DAS General Conceptual Ability and ADOS results (x = 
0.082-0.128, p=0.568-0.708). 
When the perinatal and childhood histories of the participants who reached 
abnormal cutoffs in the social (n=4) or communication (n=7) ADOS domains, or on the 
ADOS total (n=3), were compared with the rest, there were no significant differences 
observed in the occurrence of ROP, IVH, BPD, cardiac anomalies, seizure disorders, 
developmental brain abnormalities, or mental retardation, or in the mode of delivery 
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(p=0.17-1.00; see Table D). None of the study participants had a history of congenital 
infection, traumatic brain injury or other postnatal injury, inborn error of metabolism, 
maternal drug use, forceps use, or neonatal resuscitation. 
~ 
Communication Score Social Score Total Score 
Factor Normal Abn Normal Abn Normal Abn 
n=12 n=7 p value n=15 n=4 p value n= 16 n=3 p value 
ROP 7 (58%) 2 (29%) 0.350 8 (53%) 1 (25%) 0.582 8 (50%) 1 (33%) 1.000 
IVH 5 (42%) 1 (14%) 0.333 5 (33%) 1 (25%) 1.000 6 (38%) 0 0.517 
BPD 4 (33%) 0 0.245 4 (27%) 0 0.530 4 (25%) 0 1.000 
Cardiac 
Anomaly 
6 (50%) 1 (14%) 0.173 6 (40%) 1 (25%) 1.000 6 (38%) 1 (33%) 1.000 
Seizure 
Disorder 
1 (8%) 1 (14%) 1.000 2(13%) 
■ , 
0 1.000 2(13%) 0 1.000 
Developmental 
Brain 
Abnormality 
1 (8%) 1 (14%) 1.000 2 (13%) 0 1.000 2(13%) 0 1.000 
Mental 3 (25%) 1 (14%) 1.000 2 (13%) 2 (50%) 0.178 3 (19%) 1 (33%) 1.000 
Retardation •'.A v ,;/V i; , . . ’ 
Cesarean 
Section 
7 (58%) 4 (57%) 1.000 9 (60%) 2 (50%) 1.000 9 (56%) 2 (66%) 1.000 
ADOS, Autism Diagnostic Observation Schedule; ROP, retinopathy of prematurity; IVH, intraventricular 
hemorrhage; BPD, bronchopulmonary dysplasia; Abn, abnormal, 
p values determined by Fisher’s Exact Test (2-sided). 
II. Case-control study 
Out of 300 children for whom all necessary data were available, 4 were excluded 
for diagnoses that did not fall squarely into either FDD or control groups: Childhood 
Disintegrative Disorder (2) and Multiplex Developmental Disorder (2). We included the 
remaining 296 subjects in the analysis, including 74 patients with autism, 132 patients 
with PDD, and 90 non-autistic controls. 
As demonstrated in Table E, there were no significant differences among the 
groups in age (mean 12.85-14.69 years, p=0.055) or gender distribution (p=0.944). The 
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proportion of subjects with mental retardation (IQ<70) was 45% in the autism group, 
compared to 12% in the PDD group and 21% in the control group (p<0.0005). 
' 
Table E. Baseline Patient Characteristics of Cases and Controls 
. : 
V ! ■ . 
Autism PDD Control p value 
N 74 132 90 
Mean (SD) 14.69 (6.48) years 12.85 (4.35) years 13.6 (5.31) years 0.055 
age 
Sex 14F (19%) 24F (18%) 18F (20%) 0.944 
60M (81%) 108M (82%) 72M (80%) 
IQ <0.0005* 
<70 33 (45%) 16(12%) 19(21%) 
>70 41 (55%) 116 (88%) 71 (79%) 
PDD, pervasive developmental disorder. 
* statistically significant (95% confidence interval) 
Table F shows the results of the analysis. Mean birth weight (± SD) was 3458.4 ± 
695.0 grams for the autism group, 3444.8 ± 483.4 grams for the PDD group, and 3364.3 
± 664.6 grams for the control group (p=0.523). When birth weights for children with 
IQ<70 were compared, there was a noticeable but nonsignificant trend toward higher 
birth weight in the autism group (Figure 3; p=0.132); mean birth weight for those with 
low IQ was 3514.6 ± 705.7 for the autism group, 3316.8 ± 449.7 for the PDD group, and 
3138.5 ± 614.0 for the controls. Birth weights were similar across the three groups for 
children with IQ > 70 (p=0.858), for female subjects (p=0.840), and for male subjects 
(p=0.554). 
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: 
Table F. Birth Weight and Gestational Age in Cases and Controls 
4"‘- 
_ 
N 
Mean (SD) birth 
weight, in grams 
Autism 
74 
3458.42 (695.0) 
PDD 
132 
Control 
90 
. ■ . . . - ■ . . 
IQ<70 3514.55 (705.7) 
IQ>70 3413.25 (691.7) 
F 3425.32 (521.6) 
M 3466.15 (733.1) 
3444.82 (483.4) 
IQ<70 3316.76(449.7) 
IQ>70 3462.48 (487.0) 
F 3341.6(456.8) 
M 3467.75 (488.14) 
3364.27 (664.61) 
p value 
mm 
0.523 
IQ<70 3138.46 (614.0) 0.132 
IQ>70 3424.70 (653.0) 0.858 
F 3336.49(451.6) 0.840 
M 3371.21 (710.4) 0.554 
Mean (SD) 
gestational age, 
■ in weeks. 
■y . ■ 
39.42 (2.04) 
:  . : ■ ■ 39.37(1.90) 
lplI7(VL77®Iplil 
39.20 (2.69) 
. . 
0.825 
. 
Birth weight 
category 
NBW (>2500g) 70 (94.6%) 127 (96.2%) 84 (93.3%) 
LBW (<25Q0g) 2 (2.7%) 5 (3.8%) 5 (5.6%) 
VLBW (<1500g) 2 (2.7%) 0 0 
ELBW (<1000g) 0 0 1 (1.1%) 
Total <2500g 4 (5.4%) 5 (3.8%) 6 (6.7%) 0.623 
NBW, normal birth weight; LBW, low birth weight; VLBW, very low birth weight; ELBW, extremely low 
birth weight; PDD, pervasive developmental disorder. 
Mean gestational age was 39.4 ± 2.0 weeks for the autism group, 39.4 ±1.9 
weeks for the PDD group, and 39.2 ± 2.7 weeks for the controls (p=0.825). Only 4 
(5.4%) of the autism group, 5 (3.8%) of the PDD group, and 6 (6.7%) of the control 
group fell into one of the low birth weight categories (LBW, VLBW, or ELBW); there 
was no significant difference in the percentage of children with birth weight < 2500 
grams among cases and controls (p=0.623). 

26 
aa«sii@«s:iSP 
g Autism 
PDD 
□ Control 
When adverse perinatal events and conditions (parentally reported) were 
analyzed, there were no differences observed among groups in overall concern about the 
baby’s condition during labor (p=0.992), excessive bleeding before (p=0.365) or during 
(p=0.563) labor, meconium staining (p=0.066), maternal fever and/or infection 
(p=0.543), forceps use (p=0.652), nuchal cord (p=0.201), or placental abnormalities 
(previa or abruptio; p=0.789). Likewise, there were no differences in treated (p=0.322) 
or untreated (p=0.929) jaundice, use of incubator (p=0.251), feeding difficulties 
(p=0.635), or oxygen supplementation (p=0.661). See Table G for a summary of these 
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results. There were also no differences in the proportion of cases in each group with 0-1, 
2-3, or >3 adverse conditions (p=0.849). The number of data points varies with each of 
these factors (n = 190-289), as full perinatal data was not available for all subjects. 
HP.■ .SBBS * Hi . JH .^JPHHIHI 
Table G. Summary of Parentally Reported Adverse Perinatal Factors in Cases and Controls 
_ ■>7 -v i'tm. MBS 
Factor 
Total 
n 
Adverse factor reported 
P 
value 
Autism 
group 
PDD group Control 
group 
Concern over fetal condition in 
labor 
246 
„ A 
15/59 (25.4%) 28/110(25.5%) 19/77 (24.7%) 0.992 
Excessive bleeding before 
delivery 
288 3/73 (4.1%) 2/127 (1.6%) 1/88 (1.1%) 0.365 
Meconium 249 
■ 
3/59(5.1%) 15/111 (13.5%) 
■■ ‘ . . f. 
4/79 (5.1%) 0.066 
Maternal fever/infection 190 3/46 (6.5%) 9/82(11.0%) 4/62 (6.5%) 0.543 
Excessive bleeding during 
delivery 
249 1/59(1.7%) 5/111 (4.5%) 2/79 (2.5%) 
■ 
0.563 
Forceps use 251 5/59 (8.5%) 11/111 (9.9%) 5/81 (6.2%) 0.652 
Nuchal cord 289 5/73 (6.8%) 14/127 (11.0%) 4/89 (4.5%) 0.201 
Placenta previa or abruptio 285 3/72 (4.2%) 3/124 (2.4%) 3/89 (3.4%) 0.789 
Untreated transient jaundice 280 10/67 (14.9%) 21/125 (16.8%) 15/88(17.0%) 0.929 
Jaundice requiring phototherapy 250 13/58 (22.4%) 15/112(13.4%) 14/80(17.5%) 0.322 
Incubator use 287 6/70 (8.6%) 12/128 (9.4%) 14/89(15.7%) 0.251 
Feeding difficulties 246 7/56(12.5%) 20/111 (18.0%) 14/79(17.7%) 0.635 
Oxygen supplementation 285 5/70 (7.1%) 13/127 (10.2%) 10/88(11.4%) 0.661 
PDD, pervasive developmental disorder. 
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Discussion 
Taken together, our pilot study exploring the possible connection between 
extremely low birth weight and the later development of autistic behaviors, and our case- 
control analysis of birth weight and gestational age in autistic, PDD, and control 
populations, raise several interesting points about the nature and etiology of autism. The 
first study suggests that ELBW children may be at risk for developing autism-like deficits 
in communication and reciprocal social interaction. The second leads us to conclude that 
low birth weight is not a major risk factor for autism and PDD in a larger group of 
children. 
In our study of 19 ELBW children, a higher-than-expected number scored in the 
autism and ASD ranges on the ADOS tests, suggesting that these children may be at 
higher risk than children of normal birth weight for developing deficits in communication 
and social interaction suggestive of an ASD. It should be emphasized that scoring 
abnormally on a subset of the ADOS does not, in itself, indicate a diagnosis of ASD; 
rather, it is the total score that counts. Indeed, the fact that only one child scored in the 
ASD range on all administered tests (and therefore likely falls into the diagnostic 
category of PDD-NOS) indicates that most of the children did not meet the criteria for an 
ASD despite their abnormal performance on the ADOS. Overall, 3/19 (15.8%) children 
had an ASD- or autism-level total score on the ADOS, and 1/19 (5.3%) had ASD-level 
scores on all tests; by comparison, estimated prevalence for ASDs in the general 
population is approximately 60/10,000 (0.6%). 
Although ELBW children scored abnormally on the ADOS with surprising 
frequency, we saw no correlation within the group between birth weight and ADOS 
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scores, nor between birth weight and ABC, ASQ, or Vineland scores. This lack of 
correlation may be due to the small sample size or to the possibility that while being bom 
at ELBW increases risk, there are no significant differences in risk within the small 500 
gram weight range. We did, however, see a positive correlation between gestational age 
and ADOS social scores. This correlation leads us to wonder whether some sort of 
growth restriction, resulting in children who have relatively late gestational ages but low 
birth weights, might play into later impairments in social interaction, although with such 
a small sample size this finding is difficult to generalize. Higher IQ measured earlier in 
life (as demonstrated by the Bayley Scales of Infant Development) correlated with higher 
ADOS social scores, but there was no association between social scores and IQ measured 
later in life (measured by the DAS). These findings help to dismiss notions that low IQ 
might contribute to false positive results on the ADOS. Overall, correlations using 
ADOS scores are necessarily imperfect and should be interpreted with caution because 
the ADOS uses cutoff scores for diagnosis of PDD or of autism. According to the ADOS 
design, whether a score falls above or below a given cutoff (which is a different number 
for each of the modules) is more significant than the absolute score. To correct partially 
for this, we used only module 3 data (the module given to the majority of the 
participants) for correlations. 
Mean Vineland standard scores for the ELBW children were more than one 
standard deviation below the norm in all domains, a finding that was not particularly 
surprising given the significant developmental delays and limitations in cognitive and 
executive function often seen with in this group of children. Patterns of Vineland domain 
scores for developmentally disordered children have been previously described, and can 
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be useful in discriminating autism from other disorders. One group (78) has shown that 
autistic children tend to have low socialization scores for chronological and mental age (a 
ratio of actual to age-predicted socialization scores 3.5 standard deviations below the 
normative sample is most indicative of autism). This method, however, did not prove 
useful in distinguishing PDD from other diagnoses. Other studies (79-81) have identified 
patterns of low socialization performance, intermediate communication skills, and 
relatively high function in terms of daily living skills for the autistic population. We did 
not observe such patterns in the ELBW group as a whole (in which performance in all 
adaptive behavior domains was uniformly low), but did note a pattern suggestive of 
autism in the raw domain scores of the one participant who scored in the ASD domain on 
all administered tests. This finding increases our suspicion that this individual’s 
diagnosis of an ASD was correct. 
This pilot study has several limitations. Unfortunately, despite efforts to recruit 
enough subjects for statistical significance, only 19 subjects could be fully tested, thus 
limiting the power of the study. Therefore, our data are insufficient to estimate the 
prevalence of ASDs in the ELBW population as a whole. We cannot exclude the 
possibility that our results occurred by chance alone, or as a result of patient self¬ 
selection (i.e., the possibility that parents with “problem” children were more eager to 
participate in the study). However, our results - strengthened by the corroboration of a 
blinded secondary ADOS scorer - do point to a potential connection between ELBW and 
autistic behaviors that should be further investigated on a larger scale. 
Another potential weakness centers around the lack of controls and the resulting 
potential for investigator bias. Early in the design of this pilot study, the decision was 
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made not to include a control group of normal birth weight children in order to maximize 
testing of ELBW children in the limited time available. Because standardized norms 
exist for each of the assessment tools used, the ELBW children in the study were 
compared against these norms rather than against a control group. Concerns about 
investigator bias in the ADOS test were addressed by having a second person, unaware of 
the context of the study, rescore a random sample of ADOS tests. The other three 
instruments used - the Vineland, ABC, and ASQ - were based either exclusively or 
primarily on parental response and were thus less subject to investigator bias. 
Conversely, the exclusion of children with cerebral palsy (due to the difficulty of 
administering the ADOS to such children) may have contributed to a falsely low number 
of abnormal scores. Cerebral palsy is associated with neurobehavioral disorders, 
including autism, in up to 50% of cases (82). Although there were no children with 
hearing loss severe enough to merit exclusion on our particular study, it should also be 
noted for future investigations that an association between autism and deafness has been 
shown to exist. One group (83) found moderate-severe to profound hearing loss in 10- 
15% of autistic cases. 
The ADOS is designed to catch abnormalities in communication and social 
interaction that are relatively specific to disorders in the autism spectrum. Our findings 
suggest that the subtle deficits picked up during ADOS testing in several of the ELBW 
children are similar in character to those seen in autism and autism spectrum disorders, 
even though these children would not be diagnosed as having an ASD. Furthermore, 
given that outcomes in autistic children can be markedly improved by early intervention, 
it is possible that timely recognition and management of these subtle problems with 

32 
communication and sociability may be beneficial to those ELBW children who are 
affected. 
Thus, although our data cannot be used reliably to estimate the prevalence of ASD 
in the ELBW population, we offer clinically interesting results that we hope will inform 
the design of larger, controlled studies. The sample size needed for a definitive study 
comparing ASDs in ELBW and control populations would require between 200 and 
several thousand subjects per group, depending on initial assumptions, and would likely 
necessitate a coordinated effort by several institutions caring for ELBW children. 
For the second part of this work - the case-control study - we calculated sample 
size ahead of time to avoid the difficulties with low statistical power encountered in the 
first part. Our case and control groups were similar in mean age and gender distribution. 
As expected, the autistic group had a higher incidence of mental retardation than the 
other two groups. We observed no significant differences in birth weight or gestational 
age among the autism, PDD, and control groups as a whole or when the groups were 
stratified according to IQ or gender. In the active debate over birth-related etiologies of 
autism, this finding supports those studies that suggest that birth weight is not a 
significant risk factor for autism. Likewise, we found no relationship between adverse 
perinatal factors (nonreassuring fetal status during labor, excessive maternal bleeding, 
meconium staining, maternal fever or infection, forceps use, nuchal cord, placental 
abnormalities, hyperbilirubinemia, incubator use, feeding difficulties, or oxygen 
supplementation) and the development of autism or PDD. 
Interestingly, within the subgroup of participants with mental retardation, autistic 
subjects had higher birth weights than PDD subjects, who in turn had higher birth 
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weights than controls, although this trend was not significant within the 95% confidence 
interval. Low birth weight has been classically associated with cognitive deficits - 
secondary to neurologic damage (from trauma, asphyxia, or spontaneous intracerebral 
hemorrhage) related to the underdeveloped brain and body of the premature infant - but 
the autistic children with MR had even higher birth weights than the autistic group as a 
whole. This implies that cognitive deficits in autistic children may stem from a 
secondary process unrelated to birth parameters, perhaps the same neurologic process that 
has caused the autism itself. Such an idea fits nicely with the abnormal brain growth 
hypothesis of autism, referenced earlier in this paper (17), in suggesting that something 
happens to the brain after birth (be it formation of abnormal neural connections, glial 
proliferation, or some other as yet undefined process) to cause autism and also, in many 
cases, concurrent mental retardation. 
In conclusion, the findings of these two related studies produce an interesting 
picture about the nature and root causes of autism. Many experts now believe that 
disorders within the autism spectrum are likely the end result of a variety of factors, 
genetic and/or environmental, rather than the consequence of a single defined set of 
events or insults. That is, the cause of autism is almost certainly not the same for all 
affected individuals. Thus, while our data demonstrate that low birth weight is unlikely to 
be a major risk factor for ASDs, it is possible that the small subgroup bom at ELBW (and 
thus at special risk for neurologic sequelae) may have a tendency to develop autism-like 
behavioral derangements even if low-birth-weight children in general do not. Given the 
striking prevalence of subtle deficits in social and communication skills seen in the 
ELBW children in this study, as well as the potential for correcting these deficits with 

early intervention, we eagerly await the generation of additional data to determine 
whether screening ELBW children for autism-like deficits is warranted. 
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APPENDIX A 
DSM-IV CRITERIA FOR AUTISTIC DISORDER (299.0) 
I. A total of at least six items from (A), (B), and (C), with at least two from (A), and one each 
from (B) and (C) 
A. Qualitative impairment in social interaction, as manifested by at least two of the 
following: 
1. marked impairments in the use of multiple nonverbal behaviors such as eye- 
to-eye gaze, facial expression, body posture, and gestures to regulate social 
interaction 
2. failure to develop peer relationships appropriate to developmental level 
3. markedly impaired expression of pleasure in other people’s happiness 
4. lack of social or emotional reciprocity 
B. Qualitative impairments in communication as manifested by at least one of the following: 
1. delay in, or total lack of, the development of spoken language (not 
accompanied by an attempt to compensate through alternative modes of 
communication such as gesture or mime) 
2. in individuals with adequate speech, marked impairment in the ability to 
initiate or sustain a conversation with others 
3. stereotyped and repetitive use of language or idiosyncratic language 
4. lack of varied, spontaneous make-believe play or social imitative play 
appropriate to developmental level 
C. Restricted repetitive and stereotyped patterns of behavior, interests and activities, as 
manifested by at least one of the following: 
1. encompassing preoccupation with one or more stereotyped and restricted 
patterns of interest that is abnormal either in intensity or focus 
2. apparently inflexible adherence to specific, nonfunctional routines or rituals 
3. stereotyped and repetitive motor mannerisms (e.g hand or finger flapping or 
twisting, or complex whole-body movements) 
4. persistent preoccupation with parts of objects 
II. Delays or abnormal functioning in at least one of the following areas, with onset prior to age 3 
years: 
A. Social interaction 
B. Language as used in social communication 
C. Symbolic or imaginative play 
III. The disturbance is not better accounted for by Rett's Disorder or Childhood Disintegrative 
Disorder 
From the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. 1994. Washington, DC: 
American Psychiatric Association. 886 pp. 
APPENDIX B 
I. The Autism Diagnostic Observation Schedule - Generic 
“The Autism Diagnostic Observation Schedule - Generic (ADOS-G), is a semi-structured 
assessment of social interaction, communication, play and imaginative use of materials for individuals 
who may have autism or other pervasive developmental disorders (PDD). As port of the schedule, 
planned social occasions, referred to as “presses”, are created which a range of social initiations and 
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resonses is likely to appear. In the same way, communication opportunities are designed to elicit a 
range of interchanges. Play situations are included to allow observation of a range of imaginative 
activities and social role-play. The goal of the ADOS-G is to provide presses that elicit spontaneous 
behaviors in standardized contexts. Structured activities and materials, and less structured interactions, 
provide standard contexts within the ADOS-G in which social, communicative and other behaviors 
relevant to the understanding of pervasive developmental disorders are observed.... 
“The modules provide social-communicative sequences that combine a series of unstructured 
and structured situations. Each situation provides a hierarchy of presses for particular social behaviors. 
Module 1... is intended for children who do not use spontaneous phrase speech consistently. It 
consists of 10 activities with 29 accompanying ratings. Module 2 is intended for children with some 
flexible phrase speech who are no verbally fluent. It consists of 14 activities with 28 accompanying 
ratings. Module 3 provides 13 activities and 29 ratings. It is based on the ADOS and is intended for 
verbally fluent children for whom playing with toys is age-appropriate. The operational definition of 
verbal fluency is the spontaneous, flexible use of sentences, with multiple clauses that describe logical 
connections within a sentence. It requires the ability to talk about objects or events not immediately 
present. Module 4 contains the socioemotional questions of the ADOS, along with interview items 
about daily living and additional tasks. It is intended for verbally fluent adults and for adolescents 
whoa re not interested in playing with toys such as actions figures (usually over 12-16 years). This 
module consists of 12-15 activities with 30 accompanying ratings.” 
Cutoff scores for ADOS domains: 
Module 1 
Communication: autism cut-off = 4, autism spectrum cut-off -2 
Reciprocal Social Interaction: autism cut-off = 7, autism spectrum cut-off -4 
Communication + Social (Total): autism cut-off = 12, autism spectrum cut-off =7 
Module 2 
Communication: autism cut-off = 5, autism spectrum cut-off =3 
Reciprocal Social Interaction: autism cut-off = 6, autism spectrum cut-off =4 
Communication + Social (Total): autism cut-off = 12, autism spectrum cut-off =8 
Module 3 
Communication: autism cut-off = 3, autism spectrum cut-off -2 
Reciprocal Social Interaction: autism cut-off = 6, autism spectrum cut-off =4 
Communication + Social (Total): autism cut-off = 10, autism spectrum cut-off =7 
From Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, et al. 2000. The Autism Diagnostic 
Observation Schedule-Generic: a standard measure of social and communication deficits associated 
with the spectrum of autism. JAut Dev Disord. 30(3):205-223. 
II. Autism Behavior Checklist 
“The Autism Behavior Checklist (ABC) is a checklist of nonadaptive behaviors, capable of 
providing a general picture of how an individual ‘looks’ in comparison with others. The profile of an 
individual’s behavior is accomplished by quantifying the behavioral characteristics on the checklist.” 
Either the teacher or the parent completes the checklist, which asks questions about behaviors 
in five domains: sensory, relating, body and object use, language, and social and self-help. The total 
score, derived from the sum of scores in these five areas, is predictive of a diagnosis of autism. “An 
ABC score of 68 or higher has been selected as a high-probability cutoff point for the classification of 
autism. Scores between 54-67 fall within one standard deviation of the autistic samples studied. ABC 
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scores between 54-67 are considered to be in the moderate-probability range for the classification of 
autism. Scores between 47-53 may cause administrators confusion... Diagnosis and educational 
planning for these borderline individuals are greatly facilitated by administering [other tests].” 
From Krug DA, Arick JR, Almond PA. 1993. Autism Screening Instrument for Educational Planning, 
Second Edition: Examiner’s Manual. Austin, TX: ProEd. 
III. Autism Screening Questionnaire 
The Autism Screening Questionnaire (ASQ) “consists of 40 questions that are based on the 
ADI-R [Autism Diagnostic I nterview-Revised] but which have been modified into a form 
understandable by parents without further explanation. These are questions on reciprocal social 
interaction (such as social smiling, interest in other children, and offering comfort to others), language 
and communication (including the use of conventional gestures, reciprocal conversation, and 
stereotyped utterances), and repetitive and stereotyped patterns of behaviours (including circumscribed 
interests and unusual preoccupations). In addition, the ASQ includes a question about self-injurious 
behaviour and a question about the individual’s current language functioning.” 
“Scores of 15 or more [are suggested] as the standard optimal cut-off for differentiating PDDs 
(including autism) from other diagnoses. The sensitivity was 0.85, specificity 0.75, positive predictive 
value 0.93, and negative predictive value 0.55 [in the sample tested].... A much higher cut-off (22 or 
more) [are] required to separate autism from PDDs, the sensitivity being 0.75 and specificity 0.60 at 
that point.” 
From Berument SK, Rutter M, Lord C, Pickles A, Bailey A. 1999. Autism screening questionnaire: 
diagnostic validity. Br J Psychiatry. 175:444-451. 
IV. Vineland Adaptive Behavior Scales 
‘The Vineland Adaptive Behavior Scales... assess personal and social sufficiency of 
individuals from birth to adulthood. The scales are applicable to handicapped and nonhandicapped 
individuals. Like the original, the revised Vineland does not require the direct administration of tasks 
to an individual, but instead requires a respondent who is familiar with the individual’s behavior.... 
[The revised Vineland] measures adaptive behavior in four domains: Communication, Daily Living 
Skills, Socialization, and Motor Skills. In addition, [it includes] a Maladaptive Behavior domain, the 
administration of which is optional. 
“The Survey Form, containing 297 items, provides a general assessment of adaptive behavior, 
which is useful for determining areas of strength and weakness. A trained interviewer administers the 
Survey Form to a parent of caregive of an individual from birth to 18 years 11 months or a low- 
functioning adult. The semi-structured interview typically lasts between 20 and 60 minutes. The user 
of the Survey Form obtains norm-referenced information based on the performance of representative 
national standardization samples of about 4,800 handicapped and nonhandicapped individuals.” 
Raw scores obtained in the domains of the Vineland are then converted into standard scores 
according to chronological age. “Standard scores express in standard deviation units the extent to 
which the individual’s score exceeds or falls below the mean score of persons the same age with whom 
the instrument was standardized.... Vineland standard scores have a mean of 100 and a standard 
deviation of 15.” 
From Sparrow SS, Balia DA, Cicchetti DV. 1984. Vineland Adaptive Behavior Scales: Interview 
Edition, Survey Form Manual. Circle Pines, MN: American Guidance Service. 
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